Investigating the phase 2 clinical trial data on BNT327/PM8002 Combined with Chemotherapy for Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Executed on:Apr 29, 2025 3:00 PM EDT

Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert

Institution: Cleveland Clinic

Vice Chair of the Department of Hematology and Medical Oncology at Cleveland Clinic Taussig Cancer Center.
Thoracic medical oncologist with over 20 years of clinical experience; Active clinical investigator in trials involving NSCLC and small cell lung cancer as well as mesothelioma.
Treats 20-25 new NSCLC patients per month and currently manages over 200 active patients with NSCLC.

Interview Goal

The call will discuss the Phase 2 clinical trial results of BNT327/PM8002 combined with systemic chemotherapy as a first-line therapy for extensive-stage small cell lung cancer (ES-SCLC), highlighting its efficacy and safety profile.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.